Expect lots of negative comments and downgrades as big institutions short EMR. Personally, I don't believe that the currency impact will last for my holding period, so I see this as a good time to accumulate shares. Company is well run and the currency issue will pass.
I don't like what I see. From a governance stand point Dr. Jiang is doing too much. They need a qualified CFO. Tong struggled to build a relationship with a US counterpart. Who put the alliance together? You can read the recent events as good or bad. At the end of the day, results will matter.